Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper: Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://ncbi.nlm.nih.gov/pubmed/27764779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12737
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge